6th Cannabinoid-Derived Drug Development Summit Hilton Boston Back Bay, Boston

With a brand-new agenda, the 6th Cannabinoid-Derived Drug Development Summit is the ideal platform for preclinical and clinical scientists, R and D leaders, and drug developers to keep up with the latest innovations in cannabinoid in vivo and in vitro translation, bioavailability, dosage and delivery, and choosing clinical trial outcomes.

Join forces with industry leaders like Jazz Pharmaceuticals, GB Sciences, Alterola, Avicanna and Roche as they collaborate to overcome DMPK, clinical placebo effect, and translational potency; and discuss novel translational and clinical data for neurology and pain, cardiometabolic, dermatology, oncology and more.

Meet with over 80 scientists to achieve FDA accepted and patient compliant dosage regimes for CBD therapeutics, and be part of intimate discussions only available, year on year, at this conference.